Returns–Not enough quarters yet
These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.
Top holdings
At the end of June 30, 2026. Change is in shares since the quarter before.2
| Stock | Value | Share of portfolio | Change |
|---|---|---|---|
| WAYWaystar Hldg Corp | $510.8M | 59.2% | |
| Pharvaris N VCUSIP N69605108 | $118.4M | 13.7% | |
| Oculis Holding AgCUSIP H5870P102 | $96.4M | 11.2% | +17.8% |
| EVMNEvommune Inc | $70.3M | 8.1% | +7.3% |
| AGMBAgomab Therapeutics Nv | $66.7M | 7.7% |
Best picks still held
How each current holding has done since the quarter it first appeared in its filings (up to six years back).
| Stock | Held since | Return since | Now worth |
|---|---|---|---|
| Pharvaris N VCUSIP N69605108 | September 30, 2025 | +38.6% | $118.4M |
| AGMBAgomab Therapeutics Nv | March 31, 2026 | +23.7% | $66.7M |
| Oculis Holding AgCUSIP H5870P102 | September 30, 2025 | −21.1% | $96.4M |
| EVMNEvommune Inc | December 31, 2025 | −22.4% | $70.3M |
| WAYWaystar Hldg Corp | September 30, 2025 | −45.9% | $510.8M |
Quarter by quarter
| Quarter | Its picks | S&P 500 |
|---|---|---|
| June 30, 2026 | −17.4% | +14.8% |
| March 31, 2026 | −13.1% | −4.6% |
| December 31, 2025 | −5.2% | +2.4% |
| December 31, 2022 | +21.0% | +7.1% |
| September 30, 2022 | −38.1% | −5.3% |
Sources
Every number on this page points here. Each one links to the public record.
- 1SEC EDGAR: EQT Fund Management S.a r.l. Form 13F filingshttps://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1834239&type=13F-HR&dateb=&owner=include&count=40CIK 1834239
- 2SEC: 13F for the quarter ended June 30, 2026https://www.sec.gov/Archives/edgar/data/1834239/000119312526349398/Filed August 13, 2026 · accession 0001193125-26-349398